Others

Items 5851-5900 of 13505

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Drug Intermediate

    4-Acetoxycinnamic acid is an acetate ester derived from the condensation of the hydroxy group of trans-4-coumaric acid with acetic acid. This compound belongs to the cinnamic acid family and the phenyl acetate class. 4-Acetoxycinnamic acid is primarily utilized as a drug intermediate, facilitating the synthesis of various pharmaceutical compounds, and is of interest in research related to anti-inflammatory and antioxidant activities.
  2. Drug Intermediate

    (S)-2-Methylazetidine hydrochloride is a versatile drug intermediate that plays a crucial role in the synthesis of a variety of biologically active compounds. Its structural properties make it valuable for medicinal chemistry and pharmaceutical research applications. This compound is significant for developing new therapeutic agents and exploring chemical interactions in drug formulation.
  3. Drug Impurity

    Metoprolol Impurity 42 is a known impurity associated with the beta-blocker Metoprolol. This compound is primarily used for analytical research applications to assess drug purity and stability. Its presence may provide insights into the metabolic pathways and degradation products related to Metoprolol, aiding in quality control and regulatory compliance studies.
  4. Drug Impurity

    Ribociclib Impurity 2 is a known impurity associated with the cyclin-dependent kinase 4 and 6 inhibitor Ribociclib. This compound is utilized primarily in the characterization and quantification of drug purity in pharmaceutical formulations. Its presence may affect the pharmacological profile and efficacy of Ribociclib, making it an important compound for quality control and regulatory compliance in drug development and research applications.
  5. Drug Impurity

    Vitamin Impurity 4 is a chemical impurity associated with vitamin compounds, primarily impacting drug safety and efficacy evaluation. This reagent is commonly utilized in quality control assessments within pharmaceutical research, helping to ensure compliance with regulatory standards. Its role as an impurity provides crucial insights into the stability and purity of vitamin formulations, making it an essential tool for researchers involved in vitamin-related studies.
  6. Drug Impurity

    Rebamipide impurity 6 is a known impurity associated with Rebamipide, a therapeutic agent primarily targeting mucosal protection in gastrointestinal disorders. This compound is essential for analytical studies and quality control processes in pharmaceutical research. Its identification and characterization aid in understanding the compound's stability and efficacy profiles.
  7. Drug Intermediate

    3-Methyl-1-tosyl-1H-pyrazol-5-amine serves as a chemical intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structure facilitates modification for the development of compounds exhibiting desired biological activities. This reagent is instrumental in research focused on drug discovery and optimization processes.
  8. Drug Intermediate

    (S)-4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline serves as an important drug intermediate in the synthesis of various active pharmaceutical ingredients. Its unique structural features facilitate diverse modifications for the development of bioactive compounds. This reagent plays a crucial role in medicinal chemistry research, enabling the exploration of potential therapeutic applications.
  9. Drug Impurity

    Vonoprazan impurity 6 is a chemical impurity associated with Vonoprazan, a proton pump inhibitor. It serves as an important reference standard for analytical and quality control purposes in the pharmaceutical industry. The characterization of this impurity aids in ensuring the purity and safety of Vonoprazan formulations, contributing to the rigorous standards of drug development and regulatory compliance.
  10. Drug Intermediate

    21-Chloro-3,6,9,12,15-pentaoxahenicosan-1-ol serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. Its structural attributes facilitate subsequent chemical modifications necessary for the development of pharmaceuticals. This reagent plays a vital role in medicinal chemistry research and can be effectively utilized in the design and synthesis of novel therapeutic agents.
  11. Drug Intermediate

    3-Fluorobutan-1-amine hydrochloride is a valuable drug intermediate that facilitates the synthesis of diverse bioactive compounds. Its structural properties support various chemical modifications, making it essential for research in medicinal chemistry and pharmacology. This reagent is instrumental in developing novel therapeutics and studying biological pathways.
  12. Drug Impurity

    (S)-Ponesimod is a chiral impurity associated with the selective S1P receptor modulator, Ponesimod. Its presence is relevant in the development and quality control of therapeutic formulations targeting autoimmune diseases. Research applications include assessing drug purity and understanding the pharmacokinetics of S1P receptor modulators.
  13. Drug Intermediate

    4-Fluorobenzene-1,3-dicarboxylic acid is a versatile drug intermediate utilized in the synthesis of various active pharmaceutical compounds. This compound serves as a critical building block in the development of drugs, facilitating the introduction of functional groups and structural modifications. Its applications extend to diverse fields within medicinal chemistry, making it an essential reagent for chemical research and development.
  14. Drug Intermediate

    Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate serves as a crucial intermediate in drug synthesis. This compound is utilized in the development of a variety of bioactive molecules, facilitating research in medicinal chemistry and pharmaceutical development. Its structural complexities contribute to the enhancement of pharmacological profiles in active compounds, paving the way for novel therapeutic agents.
  15. Drug Intermediate

    BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid is a synthetic intermediate that plays a crucial role in pharmaceutical synthesis. This compound provides a versatile building block for the development of novel bioactive molecules, facilitating the creation of potential drug candidates. Its structural properties make it ideal for applications in medicinal chemistry and drug formulation research.
  16. Drug Intermediate

    7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one is a chemical intermediate widely utilized in the synthesis of diverse bioactive compounds. This compound serves as a critical building block in pharmaceutical research and development, facilitating the creation of novel therapeutic agents. Its structural features make it suitable for applications in organic synthesis and medicinal chemistry.
  17. Drug Intermediate

    (E)-4,6-dichloro-2-styrylpyrimidine is a versatile drug intermediate that plays a crucial role in the synthesis of various bioactive compounds. Its unique structural properties facilitate the formation of complex chemical entities, making it a valuable reagent in pharmaceutical research and development. This compound is utilized in the creation of targeted therapeutics, particularly in studies focused on pyrimidine derivatives and their biological activity.
  18. Drug Intermediate

    1-(4-(Trifluoromethoxy)phenyl)piperazine hydrochloride serves as a key drug intermediate in the synthesis of various active pharmaceutical compounds. This reagent is essential for generating complex molecular structures and enhances the development of potential therapeutic agents. Its unique trifluoromethoxy substituent contributes to optimized biological activity across multiple research applications in medicinal chemistry.
  19. Drug Impurity

    Quetiapine impurity 25 is a drug impurity related to Quetiapine, an atypical antipsychotic. This impurity may be utilized in the evaluation of the quality and efficacy of pharmaceutical formulations containing Quetiapine. Its characterization is essential for ensuring compliance with regulatory standards and for understanding the metabolic pathways and potential side effects associated with Quetiapine use in clinical settings.
  20. Drug Intermediate

    GGFG-Exatecan is a synthetic intermediate designed for the development of antibody-drug conjugates (ADCs). This reagent incorporates a glycyl-glycyl-phenylalanyl-glycine tetrapeptide linker fused with the DNA topoisomerase I inhibitor Exatecan, enhancing its therapeutic potential. GGFG-Exatecan is valuable for cancer research, facilitating the investigation of targeted cancer therapies and improving drug delivery systems in oncological studies.
  21. Drug Intermediate

    3-Fluoro-4-methoxybenzaldehyde is a versatile drug intermediate that serves as a key starting material in the synthesis of the fluorinated derivative of Combretastatin A-4, a compound known for its anti-cancer properties. This intermediate enables the development of novel therapeutics in cancer research, thus facilitating the exploration of fluorinated analogs in medicinal chemistry. Its unique structural features provide significant potential for further applications in drug development.
  22. Drug Intermediate

    2-Chloro-4-nitropyridine serves as a versatile drug intermediate, primarily utilized in the synthesis of various organic compounds, including 2-chloro-4-ethoxypyridine and multiple RET kinase inhibitors. Its structural properties make it instrumental in medicinal chemistry and pharmaceutical development, facilitating the creation of targeted therapeutics for a range of biological applications.
  23. Drug Intermediate

    Furfuryl acetate serves as a valuable drug intermediate in organic synthesis. It is utilized in the production of compounds such as 5-acetoxymethyl-2-vinylfuran and 5-hydroxymethyl-2-vinylfuran, which have potential applications in pharmaceuticals. Its role in the synthesis of these derivatives highlights its importance in medicinal chemistry research.
  24. Methamphetamine Impurity

    N-Formylmethamphetamine is identified as an impurity in the synthesis of methamphetamine and serves as a by-product of the Nagai reaction. Its characterization is essential for assessing the purity of methamphetamine samples in research settings. This compound aids in studies focused on understanding synthesis pathways and enhancing analytical methods in forensic toxicology.
  25. Biochemical Reagent

    2,3-Dichlorobiphenyl is a polychlorinated biphenyl (PCB) known for its role as a biochemical reagent. This compound serves as an endocrine disruptor, impacting gonadal differentiation in the model organism Xenopus laevis. Its biological activity makes it valuable for research in environmental toxicology and developmental biology, particularly in studies examining endocrine system interference and its effects on amphibian development.
  26. SM-102 Impurity

    SM-102 N-Oxide is a structural impurity of the lipophilic compound SM-102. As an important byproduct in lipid-based research, it is utilized primarily to investigate the biophysical properties and efficacy of lipid formulations. Its presence can influence the performance characteristics in applications such as gene delivery and RNA therapeutics.
  27. Corticosteroid

    Fluocortolone pivalate is an ester derivative of Fluocortolone and functions as a corticosteroid. It exhibits anti-inflammatory and immunosuppressive properties, making it useful in the study of various skin disorders. This compound enables researchers to investigate corticosteroid mechanisms in dermatological applications and contributes to the understanding of skin inflammation and related conditions.
  28. Adenosine Derivative

    3'-TBS-OMe-Bz-rA is an adenosine derivative that serves as a key intermediate in the synthesis of modified oligonucleotides and other nucleic acid-related compounds. Its structure allows for incorporation into various nucleic acid frameworks, facilitating the study of biological processes involving RNA and DNA. Research applications include the development of therapeutic oligonucleotides and probes for molecular biology studies.
  29. p-terphenyl Derivative

    Theleganbanin B is a p-terphenyl derivative isolated from Thelephora ganbajun, demonstrating potent inhibition of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β in LPS-induced BV-2 microglial cells. This compound also inhibits the phosphorylation of JAK2/STAT3, highlighting its regulatory role in inflammatory signaling pathways. Theleganbanin B presents potential for research in the context of neurodegenerative diseases, offering insights into therapeutic strategies against neuroinflammation.
  30. Drug Intermediate

    tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate serves as a crucial drug intermediate in the synthesis of diverse biologically active compounds. Its unique structural features facilitate the development of pharmaceutical agents with potential therapeutic applications. This compound is instrumental in medicinal chemistry for the creation of novel molecules targeting specific biological pathways.
  31. Drug Intermediate

    1-Methyl-1H-indazol-5-amine is a versatile drug intermediate primarily utilized in the synthesis of TRPM5 agonists. Its chemical structure supports the development of compounds that can modulate the TRPM5 ion channel, which is involved in various physiological processes and sensory functions. This reagent is valuable for researchers focusing on drug discovery and development in the context of TRPM5-related pathways.
  32. Drug Intermediate

    2-Amino-4-bromophenol serves as a crucial intermediate in the synthesis of pharmaceutical compounds, particularly in the development of soluble guanylate cyclase (sGC) inhibitors. Its structure allows for modifications that can enhance binding affinity and specificity toward target proteins. This compound is valuable for researchers focused on cardiovascular and neuropharmacological applications where modulation of sGC activity is of interest.
  33. Drug Intermediate

    2-Chloro-5-(trifluoromethyl)pyrimidine is a crucial drug intermediate with a notable role in the synthesis of various bioactive compounds. Its structural properties enhance its utility in pharmaceutical research, particularly in the development of new therapeutic agents. This compound serves as a valuable building block for the creation of diverse pyrimidine derivatives, facilitating advancements in medicinal chemistry and drug discovery endeavors.
  34. Drug Intermediate

    (R)-5,7-Difluorochroman-4-ol serves as a crucial drug intermediate in the synthesis of bioactive compounds. Its structural characteristics facilitate the development of novel therapeutic agents, making it valuable for pharmacological research and medicinal chemistry applications. This compound's unique properties can support studies aimed at exploring and optimizing drug formulations.
  35. Drug Intermediate

    Triazabicyclodecene is a bicyclic glycone compound that serves as a valuable drug intermediate for the synthesis of amides and esters. Its unique structure facilitates chemical transformations, making it an effective building block in medicinal chemistry. This compound is particularly useful for researchers involved in the development of novel therapeutic agents.
  36. Drug Intermediate

    (4-Bromo-2-(methylamino)phenyl)diethylphosphine oxide serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical compounds. This reagent facilitates transformations critical for the development of new therapeutics, providing researchers with a versatile tool for expanding chemical libraries. Its utility in medicinal chemistry highlights its significance in drug discovery and development efforts.
  37. Drug Intermediate

    7-Methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene serves as a versatile drug intermediate in the synthesis of a range of bioactive compounds. Its unique bicyclic structure allows for modifications that can enhance the pharmacological properties of resultant molecules. This reagent is essential for researchers engaged in the development of new therapeutic agents.
  38. Drug Intermediate

    6-Chloropyrimidine-4-carboxylic acid acts as a versatile drug intermediate, primarily utilized in the synthesis of diverse active pharmaceutical ingredients. This compound is integral in the development of biologically active molecules, facilitating research applications in medicinal chemistry and drug discovery. Its structural attributes enable the formation of various derivatives, contributing to the advancement of therapeutic agents.
  39. Drug Intermediate

    2-Fluoro-5-formylbenzonitrile serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound is essential for the development of various medicinal agents, facilitating advancements in drug discovery and chemical research. Its reactive functional groups enable modifications that are significant in the creation of novel therapeutic candidates.
  40. Drug Intermediate

    Chloromethyl methyl carbonate is a versatile drug intermediate primarily used in the synthesis of diverse active pharmaceutical ingredients. It serves as an essential building block in the production of compounds due to its reactive functional groups. This reagent is valuable for research applications focusing on drug development and optimization processes.
  41. Drug Intermediate

    3-(But-3-yn-1-yl)-3-(2-iodoethyl)-3H-diazirine serves as a versatile drug intermediate in the synthesis of various bioactive compounds. Its diazirine moiety allows for unique reactivity, facilitating the formation of covalent bonds with a range of biological targets. This compound is essential for researchers focused on the development of novel pharmaceuticals and studying their interactions with biomolecules.
  42. Drug Intermediate

    1-(((4-Nitrophenoxy)carbonyl)oxy)ethyl isobutyrate serves as a crucial drug intermediate in the synthesis of various active pharmaceutical compounds. This reagent facilitates the development of biologically active molecules through its reactivity and structural properties. Its use is important in medicinal chemistry, assisting researchers in the design and production of innovative therapeutic agents.
  43. Drug Intermediate

    Adamantane-1,3,5-triol serves as a critical drug intermediate in the synthesis of various pharmacologically active compounds. Its unique structure allows for modulations that can enhance biological activity, making it valuable in medicinal chemistry research. The compound's versatile applications support investigations into novel therapeutic agents and contribute to the development of new drug formulations.
  44. Drug Intermediate

    4-Chloro-6,7-dimethoxyquinoline serves as a vital drug intermediate utilized in the synthesis of various biologically active compounds. This compound is notable for its role in the development of pharmaceuticals and research applications related to quinoline derivatives. Its chemical structure allows for versatile modifications, contributing to the discovery of novel therapeutic agents.
  45. Drug Intermediate

    tert-Butyl (3-aminobicyclo[1.1.1]pentan-1-yl)carbamate serves as a drug intermediate in the synthesis of diverse bioactive compounds. This reagent is significant in medicinal chemistry for the development of pharmaceuticals and small molecules. Its unique bicyclic structure facilitates the creation of complex molecular frameworks, making it valuable in various research applications aimed at designing new therapeutic agents.
  46. Drug Intermediate

    3-Methylazetidin-3-ol hydrochloride serves as a crucial drug intermediate in the synthesis of various active pharmaceutical ingredients. It plays a significant role in the development of novel therapeutic agents, facilitating diverse chemical transformations. This compound is essential for researchers engaged in drug discovery and medicinal chemistry applications.
  47. Drug Intermediate

    4-Chloro-5-nitro-1-tosyl-1H-pyrrolo[2,3-b]pyridine serves as an important drug intermediate in the synthesis of diverse bioactive molecules. Its structural properties enable the modification and formation of complex compounds in pharmaceutical research. This reagent is essential for advancing studies in medicinal chemistry and the development of novel therapeutic agents.
  48. Drug Intermediate

    tert-Butyl (6-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-((triisopropylsilyl)ethynyl)naphthalen-2-yl)carbamate serves as a valuable drug intermediate in the synthesis of diverse biologically active compounds. Its unique structural features facilitate the preparation of complex molecules, making it an essential tool in medicinal chemistry. This reagent is particularly relevant for research applications involving drug development and optimization.
  49. Drug Intermediate

    Abemaciclib Impurity 1 (6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole) acts as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its structural features play a significant role in chemical modifications, facilitating research applications in drug discovery and development. This intermediate is essential for advancing studies focused on targeted therapies and enhancing therapeutic efficacy.
  50. Drug Intermediate

    2-Bromo-cyclohexane-1,3-dione functions as a versatile drug intermediate, facilitating the synthesis of diverse bioactive compounds. This reagent is valuable in medicinal chemistry research, where it aids in the development of novel pharmaceutical agents through its role in various organic transformations. It is essential for researchers exploring structure-activity relationships in drug design.

Items 5851-5900 of 13505

Page
per page
Set Descending Direction